Microbiome-Independent Effects of Antibiotics in a Murine Model of Nosocomial Infections.
AMR
ESKAPE
MRSA
antibiotics
antimicrobial resistance
infection
mouse
murine model
murine models
pathogenesis
pneumonia
Journal
mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231
Informations de publication
Date de publication:
28 06 2022
28 06 2022
Historique:
pubmed:
26
5
2022
medline:
1
7
2022
entrez:
25
5
2022
Statut:
ppublish
Résumé
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common causes of hospital-acquired pneumonia. To better manage patients with MRSA pneumonia, we require a greater understanding of the host-pathogen interactions during infection. MRSA research focuses on highly virulent and cytotoxic strains, which demonstrate robust phenotypes in animal models of infection. However, nosocomial infections are often caused by hospital-acquired MRSA (HA-MRSA) isolates that exhibit low cytotoxicity and few or no phenotypes in mice, thereby confounding mechanistic studies of pathogenesis. Consequently, virulence pathways utilized by HA-MRSA in nosocomial pneumonia are largely unknown. Here, we report that conditioning mice with broad-spectrum antibiotics lowers the barrier to pneumonia, thereby transforming otherwise avirulent HA-MRSA isolates into lethal pathogens. HA-MRSA isolates are avirulent in gnotobiotic mice, mimicking results in conventional animals. Thus, the observed enhanced susceptibility to infection in antibiotic-treated mice is not due to depletion of the microbiota. More generally, we found that antibiotic conditioning leads to increased susceptibility to infection by diverse antimicrobial-resistant (AMR) pathogens of low virulence. Treatment with antibiotics leads to dehydration and malnutrition, suggesting a potential role for these clinically relevant and reducible hospital complications in susceptibility to pathogens. In sum, the model described here mitigates the impact of low virulence in immunocompetent mice, providing a convenient model to gain fundamental insight into the pathogenesis of nosocomial pathogens.
Identifiants
pubmed: 35612285
doi: 10.1128/mbio.01240-22
pmc: PMC9239109
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0124022Subventions
Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI099394
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI140754
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI105129
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121244
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI149350
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI137336
Pays : United States
Références
Nature. 2013 Jan 3;493(7430):51-5
pubmed: 23235831
Infect Immun. 2014 Nov;82(11):4889-98
pubmed: 25183728
Methods Enzymol. 1991;204:587-636
pubmed: 1658572
Nat Med. 2007 Dec;13(12):1405-6
pubmed: 18064027
Dis Mon. 1987 Dec;33(12):681-780
pubmed: 3319464
Nat Med. 2010 Feb;16(2):228-31
pubmed: 20081863
EMBO Rep. 2016 Mar;17(3):428-40
pubmed: 26882549
J Clin Invest. 2009 Jul;119(7):1931-9
pubmed: 19603548
Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
J Infect Dis. 2012 Oct;206(8):1168-77
pubmed: 22859823
Am J Pathol. 2011 Jul;179(1):199-210
pubmed: 21703402
Mucosal Immunol. 2010 Mar;3(2):148-58
pubmed: 19940845
Nature. 1983 Oct 20-26;305(5936):709-12
pubmed: 6226876
Diagn Microbiol Infect Dis. 2017 Aug;88(4):342-347
pubmed: 28529090
J Infect Dis. 2015 Jun 15;211(12):1862-74
pubmed: 25298028
Ann Intern Med. 1981 Nov;95(5):549-55
pubmed: 7294544
Elife. 2021 May 04;10:
pubmed: 33944776
J Pathol Bacteriol. 1950 Oct;62(4):541-54
pubmed: 14804233
Nature. 2014 Dec 4;516(7529):94-8
pubmed: 25409145
Mol Med. 2011 Mar-Apr;17(3-4):293-307
pubmed: 21046059
J Immunol. 2005 Sep 15;175(6):3907-19
pubmed: 16148137
J Hosp Infect. 2013 Jun;84(2):143-50
pubmed: 23602415
mBio. 2017 Oct 24;8(5):
pubmed: 29066545
Clin Exp Immunol. 2009 Aug;157(2):216-24
pubmed: 19604261
Chem Rev. 2011 Jan 12;111(1):117-51
pubmed: 21174435
Mol Microbiol. 2012 Jan;83(2):423-35
pubmed: 22142035
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
J Infect Dis. 2008 Oct 15;198(8):1166-70
pubmed: 18729780
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
J Surg Res. 2008 Dec;150(2):278-85
pubmed: 18621398
Curr Opin Microbiol. 2018 Feb;41:43-50
pubmed: 29197673
Oncologist. 2012;17(10):1329-36
pubmed: 22707509
Annu Rev Genet. 2008;42:541-64
pubmed: 18713030
PeerJ. 2019 May 31;7:e6995
pubmed: 31183253
Front Microbiol. 2018 Aug 22;9:1901
pubmed: 30186248
Nat Biotechnol. 2019 Apr;37(4):420-423
pubmed: 30778233
Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S378-85
pubmed: 18462093
Mol Microbiol. 2011 Feb;79(3):814-25
pubmed: 21255120
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6333-40
pubmed: 27527081
J Exp Med. 2020 Sep 7;217(9):
pubmed: 32602902
ILAR J. 2015;56(2):169-78
pubmed: 26323627
Cell Host Microbe. 2015 Sep 9;18(3):363-70
pubmed: 26320997
Nat Rev Microbiol. 2017 Jul;15(7):435-447
pubmed: 28420883
Mol Microbiol. 2014 Aug;93(4):664-81
pubmed: 24962815
J Infect Dis. 2017 May 1;215(9):1386-1395
pubmed: 27638942
Nat Med. 2018 Jan 9;24(1):10-19
pubmed: 29315295
PLoS One. 2011 Mar 21;6(3):e17996
pubmed: 21445311
Microbiome. 2021 Feb 1;9(1):37
pubmed: 33522966
Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S15-S28
pubmed: 28196877
Cell. 2004 Jul 23;118(2):229-41
pubmed: 15260992
Sci Immunol. 2020 Mar 27;5(45):
pubmed: 32220976
Infect Immun. 2014 Nov;82(11):4596-606
pubmed: 25135683
J Exp Med. 2008 Feb 18;205(2):287-94
pubmed: 18268041
Microbiology (Reading). 2008 Aug;154(Pt 8):2265-2274
pubmed: 18667559
mBio. 2019 Jan 2;10(1):
pubmed: 30602580
Blood Rev. 1995 Sep;9(3):183-90
pubmed: 8563520
Lancet. 2006 Mar 4;367(9512):731-9
pubmed: 16517273
Clin Infect Dis. 2012 Mar 1;54(5):621-9
pubmed: 22247123
Nat Med. 2004 Aug;10(8):842-8
pubmed: 15247912
Cell Rep. 2019 Oct 29;29(5):1074-1081.e5
pubmed: 31665625
Bioinformatics. 2020 Jun 1;36(12):3882-3884
pubmed: 32311023
J Infect Dis. 2008 Apr 15;197(8):1079-81
pubmed: 18419525
Microbes Infect. 2012 Apr;14(4):380-6
pubmed: 22178792
Infect Immun. 2011 May;79(5):1927-35
pubmed: 21402769
Mol Microbiol. 2015 Apr;96(2):388-404
pubmed: 25612137
Cell Host Microbe. 2013 May 15;13(5):584-594
pubmed: 23684309
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18091-6
pubmed: 22025717
PLoS Negl Trop Dis. 2017 Apr 19;11(4):e0005548
pubmed: 28422970
Cell Host Microbe. 2013 Oct 16;14(4):453-9
pubmed: 24139401
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
J Infect Dis. 2010 Nov 15;202(10):1593-9
pubmed: 20942648
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5883-8
pubmed: 19293374
J Infect Dis. 2008 Oct 15;198(8):1171-4
pubmed: 18752431
Trends Microbiol. 2013 May;21(5):221-9
pubmed: 23454077
Gut. 2016 Apr;65(4):575-83
pubmed: 26511795
Microbiol Mol Biol Rev. 2014 Jun;78(2):199-230
pubmed: 24847020
Infect Immun. 2007 Feb;75(2):1040-4
pubmed: 17101657